TOMMIE SEYMORE-JOLY: Open Payments
NPI 1194059030 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,241 in 100 payments from 20 companies in 2025. Trend: 2023 $1,789 · 2024 $2,060 · 2025 $2,241
Food & beverage: $2,067Education: $174
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $560 |
| UCB, Inc. | 7 | $315 |
| Galderma Laboratories, L.P. | 17 | $223 |
| Regeneron Healthcare Solutions, Inc. | 11 | $213 |
| Lilly USA, LLC | 6 | $174 |
| Kerecis Limited | 5 | $100 |
| Novartis Pharmaceuticals Corporation | 5 | $90 |
| GENZYME CORPORATION | 4 | $83 |
| ABBVIE INC. | 3 | $73 |
| PFIZER INC. | 3 | $61 |
Products named: TREMFYA, Bimzelx, DUPIXENT, NEMLUVIO, Kerecis SurgiClose, TALTZ, CIBINQO, COSENTYX.
Industry payments across TX — which companies pay providers there.
